Articles
-
1 week ago |
biospace.com | Heather McKenzie
Novavax has been a symbol of biopharma’s struggle to adjust to the onslaught of regulatory changes that have hit the vaccine space over the past four months. Company executives said they are unsure whether their newly approved next-generation COVID-19 shot Nuvaxovid will be on the agenda when the CDC’s recently revamped Advisory Committee on Immunization Practices (ACIP) meets next week. However, “ACIP is so important in vaccines . . .
-
1 week ago |
biospace.com | Heather McKenzie
Eli Lilly is on something of a tear, aiming to prove with Tuesday’s $1.3 billion acquisition of Verve Therapeutics that it’s more than just a cardio-metabolic and neuroscience company. The Indianapolis-based pharma is most famous for its obesity and type 2 diabetes drugs, Zepbound and Mounjaro, and Alzheimer’s medicine Kisunla.
-
1 week ago |
biospace.com | Heather McKenzie |Jef Akst |Annalee Armstrong |Dan Samorodnitsky
> Listen on Spotify> Listen on Apple Products> Listen on Amazon Music> Listen on iHeartThis week, BioSpace is at 50% power as Heather McKenzie and Jef Akst are off attending this year’s BIO Conference in Boston. The half-team discusses this week’s biggest news: the death of another patient who took Sarepta’s Duchenne muscular dystrophy gene therapy Elevidys.
-
2 weeks ago |
biospace.com | Heather McKenzie
On June 25, Health Secretary Robert F. Kennedy Jr.’s newly minted CDC vaccine advisors will convene for their first meeting, with COVID-19, respiratory syncytial virus and influenza vaccines all on the agenda that dropped Thursday morning. Recommendation votes, according to the federal register notice, are scheduled for COVID-19, human papillomavirus (HPV), influenza, meningococcal and respiratory syncytial virus (RSV) vaccines.
-
2 weeks ago |
biospace.com | Heather McKenzie
Literary partners Marty Makary and Vinay Prasad picked up the proverbial pen again Tuesday, publishing a new article focused on the FDA’s priorities in the Journal of the American Medical Association—incidentally, a publication that just two weeks ago, Health Secretary Robert F. Kennedy Jr. threatened to bar government scientists from publishing in.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- Tweets
- DMs Open
RT @RWPUSA: As I told Heather McKenzie here: “There’s objective truth in science, and the extreme left and extreme right have always wanted…
RT @BowTiedBiotech: 🧠 HUGE NEWS - $AZN out of Neuro!!!! Big loss for patients….disappointing “CNS really is probably better managed by ot…
#biopharma conference season is in full swing, and our very own @JefAkst and @Slabodkin will be at hashtag#ASGCT24 in Baltimore next week. https://t.co/WgYSWHxOtb